Amer Sami
Impact in
- Oncology top 10%
- Lung Cancer Research Studies
- HER2/EGFR in Cancer Research
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
-
- Immunotherapy and Immune Responses
Papers in
- Oncology 18
- HER2/EGFR in Cancer Research 5
- CAR-T cell therapy research 5
- Colorectal Cancer Treatments and Studies 3
-
- Monoclonal and Polyclonal Antibodies Research 9
- Co-authors
- Shahid Ahmed (18 shared papers)Jim Xiang (5 shared papers)Kamal Haider (11 shared papers)Sunil Kumar Yadav (6 shared papers)Riaz Alvi (3 shared papers)Ali El‐Gayed (6 shared papers)J Xiang (4 shared papers)Imran Ahmad (4 shared papers)
- Journals
- Journal of Clinical Oncology (5 papers)Cancer Gene Therapy (3 papers)Cancers (2 papers)Diseases of the Colon & Rectum (1 paper)Gene Therapy (1 paper)
- Partner nations
- CanadaUnited StatesChina
In The Last Decade
Amer Sami
23 papers receiving 562 citations
Peers
Comparison fields: 5 of 61
- Oncology 281
- Immunology 127
- Cancer Research 68
- Radiology, Nuclear Medicine and Imaging 80
- Epidemiology 78
Countries citing papers authored by Amer Sami
This map shows the geographic impact of Amer Sami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amer Sami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amer Sami more than expected).
Fields of papers citing papers by Amer Sami
This network shows the impact of papers produced by Amer Sami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amer Sami. The network helps show where Amer Sami may publish in the future.
Co-authors
The 25 scholars most cited alongside Amer Sami, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 150 | |
| 2 | 2006 | 103 | |
| 3 | 2013 | 44 | |
| 4 | 2010 | 41 | |
| 5 | 2021 | 38 | |
| 6 | 2006 | 33 | |
| 7 | 2018 | 27 | |
| 8 | 2021 | 22 | |
| 9 | 2008 | 22 | |
| 10 | 2002 | 16 | |
| 11 | 2013 | 16 | |
| 12 | 2006 | 12 | |
| 13 | 2022 | 11 | |
| 14 | 2011 | 11 | |
| 15 | 2007 | 8 | |
| 16 | 2015 | 5 | |
| 17 | 2021 | 4 | |
| 18 | 2010 | 2 | |
| 19 | 2014 | 2 | |
| 20 | 2008 | 2 |
About Amer Sami
Amer Sami is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging, Immunology, Pulmonary and Respiratory Medicine and Molecular Biology, having authored 24 papers that have together received 572 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (9 papers), Immunotherapy and Immune Responses (8 papers), HER2/EGFR in Cancer Research (5 papers), CAR-T cell therapy research (5 papers), Advanced Breast Cancer Therapies (3 papers), Breast Cancer Treatment Studies (3 papers), Colorectal Cancer Treatments and Studies (3 papers) and Glycosylation and Glycoproteins Research (2 papers). The work is most often cited by research in Oncology (281 citations), Immunology (127 citations), Cancer Research (68 citations), Radiology, Nuclear Medicine and Imaging (80 citations) and Epidemiology (78 citations). Amer Sami has collaborated with scholars based in Canada, United States and China. Frequent co-authors include Shahid Ahmed, Jim Xiang, Kamal Haider, Sunil Kumar Yadav, Riaz Alvi, Ali El‐Gayed, J Xiang, Imran Ahmad, Tim Hon Man Chan and Daygen L. Finch. Their work appears in journals such as Journal of Clinical Oncology, Cancer Gene Therapy, Cancers, Diseases of the Colon & Rectum and Gene Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.